News | February 26, 2009

Orbital Therapy Launches ClearVue in EU

February 26, 2009 – Orbital Therapy, LLC announces the commercial introduction of ClearVue, prone position breast radiotherapy treatment table, in the European Union.

ClearVue is a carbon fiber add-on treatment table used to simulate and treat breast cancer patients in the prone position. ClearVue can be used with existing CT simulators and linear accelerators to plan and deliver radiation treatment for breast cancer patients.

ClearVue reportedly has the ability to provide unobstructed view and full access to the anatomy for precise treatment set-up and delivery. The open design allows the clinician to plan a treatment from more than two conventional angles and utilize more complex treatment techniques that are already in use with other anatomies.

Prone position breast cancer treatment is quickly gaining popularity. The prone position increases the separation of the target and uninvolved critical organs and minimizes or eliminates target motion caused by breathing. This results in the ability to deliver less dose to the surrounding organs such as lung and heart, and more precise dose to the intended target, according to Orbital Therapy.

For more information:

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
U.K.'s NICE Supports Use of Hydrogel Spacer in Prostate Cancer Treatement
News | Patient Positioning Radiation Therapy | September 08, 2017
Augmenix Inc. announced that the National Institute for Health and Care Excellence (NICE) in the U.K. has issued...
Augmenix Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR Hydrogel
News | Patient Positioning Radiation Therapy | September 05, 2017
Augmenix Inc. announced that Palmetto GBA LLC — the Medicare Administrative Contractor (MAC) covering North Carolina,...
Augmenix Announces First New Zealand Prostate Cancer Patient Treated with SpaceOAR Hydrogel
News | Patient Positioning Radiation Therapy | June 28, 2017
Augmenix Inc. announced that the first patient in New Zealand has been treated with SpaceOAR hydrogel at the Kathleen...
Augmenix, SpaceOAR System, prostate cancer, new CPT code, AMA, American Medical Association
Technology | Prostate Cancer | November 10, 2016
Augmenix Inc. announced that the American Medical Association (AMA) has granted a Category I, Current Procedural...
ZDi Solutions, Z-System, radiation therapy, proton therapy, patient positioning, ASTRO 2016
News | Patient Positioning Radiation Therapy | September 23, 2016
ZDi Solutions LLC announced that it will soon market its Z-System patient positioning devices to proton therapy and...
Vision RT, AlignRT, clinical data, radiation therapy, ASTRO 2016
News | Patient Positioning Radiation Therapy | September 23, 2016
Vision RT announced it will be exhibiting at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting...
Overlay Init